An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
Phase of Trial: Phase II
Latest Information Update: 19 May 2016
At a glance
- Drugs Rebamipide (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 09 Feb 2011 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2009 New trial record.